Dear Colleague,It is our pleasure to announce we are now organizing "Melanoma Bridge 2015" and, for the first time, “ImmunoTherapy Bridge”. Both international meetings are being organized on behalf of Fondazione Melanoma Onlus, under the auspicies of Istituto Nazionale Tumori Fondazione "G. Pascale", Sidra Medical and Research Centre, the Italian Association of Medical Oncology, and the Society for Immunotherapy of Cancer (SITC).
Melanoma Bridge 2015 will be located in Naples, Italy, from December 1st to 4th under the Presidency of Paolo A. Ascierto, Francesco M. Marincola, and Nicola Mozzillo (link ai presidents melanoma bridge). On December 5th, the first ImmunoTherapy Bridge will take pace under the Presidency of Paolo A. Ascierto, Bernard A. Fox and Francesco M. Marincola (link ai presidents immunotherapy bridge). The Scientific Board of both events includes well-known experts covering different areas and based in different Countries.
The scientific program of Melanoma Bridge (link) will be organized in 6 sessions:
- Molecular and Immuno advances;
- Combination therapies;
- News in Immunotherapy;
- Tumor microenvironment and biomarkers;
- World-Wide Immunoscore Task Force meeting
- Regulatory, Health Technology Assessment, & Market Access Session
Attendees are expected from all around the world and encouraged to submit their abstracts for poster or oral presentation during.
Please don't forget that all accepted abstracts will be included in a dedicated Supplement of the Journal of Translational Medicine. The speaker of the abstracts selected for oral communication will be exempt from registration fee and invited as speakers to Naples.
As traditional at Melanoma Bridge, representatives of patient associations will have their chance to actively join the event.
We would appreciate very much if you will join us in Naples and if you would be so kind as to inform your colleagues and collaborators about “Melanoma Bridge 2015” and the first “ImmunoTherapy Bridge”.
We’re looking forward to meeting you again in Naples!
Paolo A. Ascierto
Bernard A. Fox
Francesco M. Marincola
For information please contact email@example.com